Real-World Use of Letermovir and Maribavir for CMV Prophylaxis and Treatment in Solid Organ Transplant Recipients: Clinical Outcomes and Resistance Patterns From a Dual-Center Cohort.

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/41439370

Alissa Wright; Allison Mah; Casara Hong; Christopher Lowe; Man Ting Xu; Nancy Matic; Sara Belga; Wan-Yun Polinna Tsai

Dec 24, 2025